1) testis-specific serine/threonine kinases
睾丸组织特异性丝氨酸/苏氨酸激酶
2) testis-specific serine / threonine kinases
睾丸特异性丝氨酸/苏氨酸激酶
3) serine threonine kinase
丝苏氨酸激酶
4) Serine/threonine kinase15
丝氨酸/苏氨酸激酶15
1.
Objective To identify the expression of serine/threonine kinase15 (STK15) and discuss its relationship with the clinicopathological parameters and ki67 expression in gastric carcinomas.
目的研究丝氨酸/苏氨酸激酶15(STK15)基因在胃癌组织中的表达,及其与临床病理指标以及ki67表达的关系。
5) Akt
丝氨酸/苏氨酸蛋白激酶
1.
Objective To observe the changes of Akt1,Akt2,Akt3 mRNA expression level in rat pulmonary arterial smooth muscle cells(PASMC) induced by hypoxia and to investigate the value of Akt signaling pathway in vascular reconstruction during phyoxia pulmonary hypertension(HPH).
目的通过观察缺氧致大鼠肺动脉平滑肌细胞(pu lmonary arterial smooth musc le cell,PASMC)3种丝氨酸/苏氨酸蛋白激酶(Akt1、Akt2、Akt3)mRNA的表达水平变化,初步探讨Akt信号途径在缺氧肺动脉高压(hypoxia pu lmonaryhypertension,HPH)血管重建中的作用。
2.
Objective To observe the changes of Akt3 mRNA and protein expressive level in pulmonary arterial smooth muscle cells(PASMC)induced by hypoxia in rats,and to investigate the regulatory role of Akt3 signaling pathway in hypoxia-induced pulmonary vascular remodeling.
目的通过观察缺氧致大鼠肺动脉平滑肌细胞(PASMC)丝氨酸/苏氨酸蛋白激酶3(Akt3)mRNA及其蛋白表达水平变化与低氧PASMC增殖的关系,探讨Akt3在低氧肺血管重建中的调控作用。
3.
Objective To investigate the regulating effects of PI3-K/Akt signaling pathway on the differentiation of the marrow-derived cardiac stem cells(MCSCs) induced with BMP-2 toward cardiomyocytes and to determine the possible mechanisms in signal transduction on differentiation of MCSCs toward cardiomyocytes.
目的研究磷脂酰肌醇-3激酶/丝氨酸/苏氨酸蛋白激酶(PI3-K/Akt)信号通路在骨形态发生蛋白-2(BMP-2)诱导骨髓源性心肌干细胞(MCSCs)向心肌细胞分化中的调控作用,探讨MCSCs向心肌细胞分化的信号转导机制。
6) serine/threonine kinase
丝氨酸/苏氨酸激酶
1.
The signal transduction system of cyanobacteria is constituted of two-component signal transduction system and eukaryotic-type serine/threonine kinases.
蓝藻信号转导系统主要包括二元信号转导系统和丝氨酸/苏氨酸激酶。
补充资料：庚酸睾丸素
分子式：C26H40O3
分子量：400.60
CAS号：315-37-7
性质：白色结晶性粉末。熔点为34-36℃。
制备方法：暂无
用途：临床用于男性机能减退，再生障碍性贫血等。
分子量：400.60
CAS号：315-37-7
性质：白色结晶性粉末。熔点为34-36℃。
制备方法：暂无
用途：临床用于男性机能减退，再生障碍性贫血等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条